Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
UMCG-NEOLYNC-001
Phase 1 other active
Quick answer
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer for Cervical Cancer is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Cervical Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active